High-frequency stimulation (HFS) of the subthalamic nucleus (STN) alleviates dramatically motor symptoms in Parkinson's disease, and recently it has been suggested that zona incerta (ZI) stimulation might be as beneficial to patients. We used in situ cytochrome oxidase (CoI) mRNA hybridization to investigate and compare the effects of HFS of the STN and the ZI on metabolic activity of the STN, globus pallidus (GP), and substantia nigra reticulata (SNr) in normal rats as well as in rats with 6-hydroxydopamine (6-OHDA) lesion, an animal model of Parkinson's disease. In normal rats, HFS of the STN, as well as of the ZI, induced a significant decrease in CoI mRNA expression within the STN and SNr but an increase within the GP. In 6-OHDA rats, HFS of the STN reversed dopamine denervation-induced changes in the expression of CoI mRNA in the STN, SNr, and GP. Similar results were obtained with HFS of the ZI except for the STN, which showed only a trend toward nomalization. These data suggest that the ZI, as well as the STN, are implicated in the functional mechanism of HFS supporting the involvement of GABA transmission for the reduction of neuronal activity in the basal ganglia output structures.
he subthalamic nucleus (STN) is considered to be a key structure in the functional organization of the basal ganglia playing an important role in motor control. In the current model of basal ganglia circuitry, the excitatory drive of the STN is supposed to maintain the tonic activity in the output structures of the basal ganglia. Experimental studies in rat and nonhuman primate models of Parkinson's disease have suggested that the death of dopaminergic cells in the substantia nigra pars compacta (SNc) and the subsequent decrease of striatal dopamine are leading to a hyperactivity of STN neurons (1) (2) (3) (4) (5) (6) (7) , and their efferent output structures of the basal ganglia, the substantia nigra pars reticulata (SNr), and the internal segment T of the globus pallidus (GPi; 8-10). Interestingly, lesioning of the STN can alleviate parkinsonian motor symptoms in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys (11, 12) . Moreover, a similar and clinically relevant alleviation can be achieved by applying high-frequency electrical stimulation (HFS) to the STN in MPTP-treated monkeys (13, 14) and patients presenting severe parkinsonism (15) (16) (17) (18) .
Besides STN, the zona incerta (ZI) may also play a role in the pathophysiology of involuntary abnormal movements and Parkinson's disease (19, 20) . Electrical or pharmacological manipulation of the ZI increases locomotor activity (21, 22) . Injection of bicuculline, a GABA A receptor antagonist, into the ZI as well as into the STN, produces abnormal movements contralateral to the injection (23) . Furthermore, the neuronal activity of ZI is dramatically increased in rat model of Parkinson's disease (24) . Recent clinical studies have shown that clinically effective HFS for the alleviation of parkinsonian motor symptoms is most commonly applied to the anterodorsal STN and the dorsally adjacent ZI (25, 26) .
Although benefits afforded by STN/ZI HFS are empirically acknowledged, the respective contribution of the STN or ZI to the clinical improvement remains to be experimentally studied in order to define i) the best therapeutic target and ii) the role of the ZI in the basal ganglia motor loop. The present study thus investigates metabolic changes induced in basal ganglia nuclei during HFS of the STN or the ZI in normal rats, as well as in rats with 6-hydroydopamine (6-OHDA) lesion. The expression of cytochrome oxidase subunit I (CoI) mRNA, a metabolic marker of global changes in neuronal activity (27) (28) (29) , was measured in the STN, the globus pallidus (GP), and the SNr.
MATERIAL AND METHODS
Experiments were performed on 40 adult male Wistar rats weighing 260-480 g (Elevage Janvier, France). Animals were housed at constant temperature (24°C) and humidity (45%) under a 12 h light (8:00 am-8:00 pm)/dark cycle with free access to food and water. Ten groups comprising each four animals were analyzed: five groups of normal animals (sham group without stimulation, with 130 Hz STN stimulation, 20 Hz STN stimulation, 130 Hz ZI stimulation, 20 Hz ZI stimulation) and five groups of animals with 6-OHDA lesion as previously reported (30, 31) without (sham group) or with stimulation by using the same parameters than in unlesioned animals. All experiments were performed in accordance with the guidelines laid down in the European Communities Council Directive of 24 November 1986 (86/609/EEC).
Electrical stimulation
Electrical stimulation was performed in urethane anesthetized rats according to described previously methods (29, 30, 32) , 25 days after 6-OHDA injection. A concentric bipolar stimulating electrode, tip diameter 200 µm (Phymep, France), was inserted stereotactically into the STN or the ZI. The second contact was placed at the dorsal limit of the STN for STN stimulation or in the ZI for ZI stimulation. Bipolar cathode stimuli through the tip of the electrode were delivered by an isolated stimulator (Neurolog system, Digitimer, UK). The stimulation parameters used in this study (frequency, 130 Hz; pulse width 60 µs; current intensity 400 µA) were similar to those used in human stimulation (17, 18) . The only exception was current intensity, which was adjusted for the rat (29, 30, 32) . A lower frequency of 20 Hz was also tested. Electrical stimulation of the STN or the ZI was applied for 45 min, and animals were killed by cervical dislocation immediately after stopping the stimulation.
Electrode location and assessment of nigro-striatal lesion
The brains were removed, frozen by rapid immersion in isopentane (-45°C), and stored at -80°C. They were later cut into coronal 20 µm slices at -20°C by using a cryostat (Leica, Germany), thaw-mounted onto gelatin-double-coated slides and stored at -80°C. Cresyl violet staining was used to determine the location of the tip of the stimulating electrode (Fig. 1A, B) . Only those brains in which the stimulating electrode was precisely located into the STN or the ZI were used for data analysis. The extent of striatal denervation was assessed by measuring the dopamine transporter (DAT) binding by using (E)-N-(3-iodoprop-2-enyl)-2β-carboxymethyl-3β-(4'-methylphenyl) nortropane (PE2I) as already described in several occasions (33) . Rats presenting a 90-100% DAT loss in the striatum were retained for data analysis (Fig. 1C) .
In situ hybridization histochemistry
In situ hybridization was performed, as described previously, (33, 34) using an oligonucleotide probe designed to recognize CoI mRNA (5′-AGT GGC AGA TGT AAA GTA GGC TCG GGT GTC TAC ATC TAG GCC TAC-3′; 29). The oligonucleotide (2 pmol) was tailed by the isotope at 37°C in a mixture containing 10 µl sterile water, 12.5 µl reaction buffer (sodium cocodylate 120 mM and dithiothreitol 100 mM), and 2 µl terminal deoxynucleotide transferase [all reagents DuPont/New England Nuclear (NEN), UK] with 7 µl of 35 S-dATP (82.5 µCi, NEN). After 60 min of incubation, the labeled probe was purified by using Bio-spin chromatography columns (Bio-Rad, Marnes la Coquette, France) centrifuged at 1100 g for 4 min (Z382K, Hermle, Wehingen, Germany). Dithiothreitol (1 M; 5* volume of eluted probe) was then added to eluted 35 S-dATP-labeled probe. This solution (1 µl) was counted by a liquid scintillation counter (Tricarb 1500, Packard, Meriden, CT) to assess the efficiency of labeling. Sections were allowed to hybridize at 42°C for 18 h with 150 µl of hybridization solution [50% formamide, 4× standard sodium citrate (SSC), 10% dextran sulfate, 10 mM dithiothreitol, and labeled-probe up to a final concentration of 3×10 6 cpm/ml]. They were then thoroughly washed for 30 min at room temperature in 1× SSC, 30 min at 55°C in 1× SSC, and 10 min at 55°C in 0.1× SSC. Once dehydrated and fully air-dried, both slides and autoradiographic microscale standard (Amersham Biosciences, Amersham, UK) were exposed to β-max Hyperfilm (Amersham) for 14 days at 4°C. Control experiments showed that specific hybridization signal was eliminated by unlabeled probe in excess and by pretreatment of the slides with RNase A (20 µg/ml).
Analysis of autoradiographs
The striatum was localized for DAT analysis and the STN, GP, and the SNr for CoI mRNA analysis, using the stereotactic coordinates given in Paxinos and Watson's rat brain atlas (35) . The optical density of these areas was then measured with an image analysis system (Densirag V. D2.99, Biocom, Les Ulis, France), as described previously in several occasions (33, 36) . All measured densities were in the linear range of the standard curve. Three sections per structure of each animal were analyzed by an examiner blind to experimental conditions. The three results were then averaged for each animal and converted to the amount of radioactivity bound by comparison to the standards, with reference to cortical (lateral secondary visual cortex) CoI mRNA levels. Mean radioactivity bound (fmol/mg of tissue equivalent) and SEM were calculated for each group. Data are expressed as percentage variation of the corresponding mean control value. We first checked that the intact (normal)/non-lesioned (6-OHDA-lesioned) side (left) of all groups did not differ from the radioactivity bound measured in the left side of control rats by using a one-way ANOVA. For multiple comparisons of radioactivity bounds, a two-way ANOVA (lesion and frequency of stimulation were the variables) was used to estimate overall significance followed by post hoc t-tests corrected for multiple comparisons by the method of Bonferroni (37) . A significance of corrected P values, with P<0.05, was required for rejection of the null hypothesis. These analyses were completed by using STATA program (Intercooled Stata 6.0, Stata Corporation, TX).
RESULTS

Effects of electrical stimulation of the STN
CoI mRNA expression in normal rats
HFS (130 Hz) of the STN induced a significant reduction in the level of CoI mRNA expression in the STN ( Fig. 2A) and SNr (Fig. 2B ) of the stimulated side when compared with the intact side. In the GP, a significant increase in CoI mRNA expression was observed in normal rats with 130 Hz stimulation of the STN (Fig. 2C) . In contrast, low-frequency stimulation (LFS = 20 Hz) of the STN did not affect the level of CoI mRNA expression in none of these three structures of the basal ganglia in normal rats ( Fig. 2A-C) .
CoI mRNA expression in rats with 6-OHDA lesion
In 6-OHDA-lesioned rats, the level of CoI mRNA expression was significantly higher in both the STN ( Fig. 2A ) and the SNr (Fig. 2B) than the level usually observed in normal control rats (7, 29) . In comparison to control rats, a significant decrease in CoI mRNA expression was observed in the GP ipsilateral to the 6-OHDA-injection (Fig. 2C) .
In 6-OHDA-lesioned rats, HFS of the STN induced a normalization of CoI mRNA levels in both the STN ( Fig. 2A) and GP (Fig. 2C ) compared with 6-OHDA-lesioned rats without STN stimulation. In the SNr, HFS of the STN not only reversed changes in the expression of CoI mRNA but decreased the expression to a level that is significantly lower than that of normal animals (Fig. 2B) .
LFS (20 Hz) of the STN in 6-OHDA-lesioned rats did not induce any significant change in the level of CoI mRNA expression in the STN ( Fig. 2A) and SNr (Fig. 2B) . However, a normalization of the expression was observed in the GP (Fig. 2C) .
Effects of electrical stimulation of the ZI
CoI mRNA expression in normal rats
HFS of the ZI induced a significant decrease in the level of CoI mRNA expression in the SNr (Fig. 3B ) of the stimulated side and a significant increase in the GP (Fig. 3C) . However, no significant change was observed in the level of CoI mRNA expression in the STN (Fig. 3A) . LFS of the ZI did not affect the level of CoI mRNA expression in the three studied structures of the basal ganglia in normal rats (Fig. 3A-C) .
CoI mRNA expression in rats with 6-OHDA lesion
In 6-OHDA-lesioned rats, HFS of the ZI did not shows any significant change in the level of CoI mRNA expression in the STN (Fig. 3A) . In the SNr, HFS of the ZI not only reversed changes in the expression of CoI mRNA but decreased the expression to a level that is significantly lower than that of normal animals (Fig. 3B) . In the GP, HFS of the ZI normalized the level of CoI mRNA expression in 6-OHDA-lesioned rats (Fig. 3C) .
LFS (20 Hz) of the ZI in 6-OHDA-lesioned rats induced a normalization of the level of CoI mRNA expression in the SNr (Fig. 3B) . However, it did not induce any significant change in the STN (Fig. 3A) and GP (Fig. 3C ).
DISCUSSION
This study shows that HFS of the STN reverses the pathological changes in metabolic activity in STN, GP, and SNr and that HFS of the ZI reverses changes in SNr and GP in an experimental rodent model of Parkinson's disease.
Methodological considerations
It is now well-established that CoI mRNA expression is a reliable surrogate marker of neuronal activity. The measurement of COI mRNA expression allows an assessment of global changes in functional neuronal activity (27) (28) (29) . Moreover, it has been shown that the distribution of Na + /K + -ATPase, which is the most important ion pump for energy requirement, and cytochrome oxidase in the brain is similar and that these two enzymes are regulated in parallel by neuronal functional activity (38) . More recently, the relationship between CoI mRNA expression and electrical neuronal activity of STN neurons was studied in 6-OHDA lesioned rats (7), revealing parallel changes in CoI mRNA expression, firing rate and firing pattern of STN neurons after 6-OHDA lesion.
CoI mRNA expression in the ZI was not quantified because of three reasons: first, the ZI is a structure with a low neuronal density; second, we used a macroscopic analysis of CoI mRNA expression, which is not sensitive enough for such a heterogeneous structure; finally, even when using microautoradiographic analysis at the cell level of CoI mRNA expression (24) , only a transient increase in CoI mRNA expression can be observed in the ZI after the degeneration of the nigro-striatal dopaminergic pathway, which do not match with the stable increase in the discharge firing rate. Thus, it is very unlikely that these changes would have persisted for 25 days after 6-OHDA lesioning, that is, when HFS was applied.
Effects of HFS of the STN in normal and 6-OHDA lesioned rats
In normal rats, HFS of the STN induced a decrease in the level of CoI mRNA expression in the STN and SNr, suggesting a reduction in the global metabolic activity of these two nuclei. From these results we can postulate that HFS of the STN inhibits the stimulated site resulting in a reduction of the activity of its efferent structure, the SNr, which is considered as the principal output structure of the basal ganglia in the rat. These results are in agreement with previous electrophysiological data. In vivo (30, 32) and in vitro (39) studies suggested that HFS of the STN can induce a reduction in the neuronal activity of STN neurons, which results in a decrease of SNr neuronal activity in the rat (30, 32) . However, because artifacts masked the recorded signal, the stimulation period could not be analyzed in these reports. More recently, this methodological difficulty has been overcome with the template subtraction method and a partial or even total cessation of electrical activity in a clear majority of STN and SNr neurons during stimulation has been shown (40) .
In rats with 6-OHDA lesion, the level of CoI mRNA expression was increased in the STN and the SNr reflecting a functional hyperactivity of these two nuclei. These data comply with previous metabolic and electrophysiological studies in 6-OHDA-lesioned rats (3, (5) (6) (7) 9 , 10, 41), in MPTP-treated monkeys (1, 2, (42) (43) (44) , and in parkinsonian patients (42, 43, 45, 46) . In GP, we observed a significant decrease in the level of CoI mRNA expression in rats with 6-OHDA lesion. Studies in 6-OHDA-lesioned rat or MPTP-treated monkey provide conflicting data about the changes in the activity of GP. Several studies have reported a decrease in the firing activity of GP neurons (1, 8, (47) (48) (49) , whereas others have shown no change (3, 4, 50, 51) or even an increase (29, (52) (53) (54) . Our results support the concept of decreased GP activity.
In 6-OHDA lesioned rats, HFS of the STN reversed dopamine denervation-induced changes in the expression of CoI mRNA in the STN, SNr and GP. As in normal rats, HFS of the STN decreased the metabolic activity of STN and SNr in 6-OHDA-lesioned rats. These results are consistent with the hypothesis that HFS of the STN alleviates parkinsonian motor symptoms by decreasing STN neuronal activity, which results in a reduction of glutamatergic tone from the STN to the output structures of the basal ganglia. In agreement, electrophysiological data showed that HFS of the STN decreased neuronal activity in SNr of 6-OHDA-lesioned rats (30, 40) . In addition, metabolic studies reported that HFS of the STN induced a reduction of the dopamine lesion-mediated increase in GAD67 mRNA levels in the SNr (29) . Similar results were obtained after subthalamotomy in MPTP-treated monkey (55) . In GP, HFS of the STN induced a normalization of the metabolic activity in 6-OHDA lesioned rats in agreement with metabolic and electrophysiological studies after STN lesioning in 6-OHDA-lesioned rats (50, 56) . In MPTP-treated monkey, Hashimoto et al. (57) have shown that HFS of the STN increases the firing rate of GPe neurons (the equivalent of GP in rodents). Our results are in agreement with these electrophysiological data. However, the same authors reported that the increase in neuronal activity was also observed in GPi, suggesting an activation via excitation of STN efferent fibers. Nevertheless, from our recent data and those of others, it is clearly demonstrated that STN HFS inhibits the majority of STN neurons in 6-OHDA rats (40) and parkinsonian patients (58) . Only few cells are excited. In agreement with these observations, a recent microdialysis study reported that, in 6-OHDA lesioned rats, HFS of the STN did not affect the level of glutamate in the SNr, but significantly increased GABA levels (59).
Our evidences support the assumption that HFS of the STN mimics the effects of STN lesion by reducing, possibly abolishing, neuronal activity in the STN and the output structures of basal ganglia.
The mechanism by which HFS decreases the activity of STN and SNr neurons is not clearly determined. In recent in vitro studies, it has been reported that HFS exercises a direct effect on the membrane of STN neurons mediated by a blockade of Na + and Ca 2+ voltage-gated currents (39, 60) . The inhibitory effect observed in the SNr could be due, at least in part, to the alleviation of excitatory glutamatergic afferents from the STN. Moreover, as HFS of the STN not only reversed changes in the expression of CoI mRNA in the SNr but decreased the expression to a level that is lower than that of controls, it is possible that the decrease of glutamatergic transmission is reinforced by the activation of GABAergic pallidonigral projections. The involvement of GABA transmission in the reduction of SNr metabolic activity is provided by anatomical studies showing that the projection from the STN to the SNr represents only 10% of the total population of terminals (61, 62) . In contrast, the projections from the GP to the SNr account for 48% of the total population of terminals in contact with the perikarya of SNr neurons (63) . It is possible that the pronounced decrease in the level of CoI mRNA in SNr combined with the normalization of the level in STN is needed for the improvement of motor symptoms.
Effects of HFS of the ZI in normal and 6-OHDA lesioned rats
In normal rats, HFS of the ZI decreased the metabolic activity in SNr and increased that of GP. In rats with 6-OHDA lesion, HFS of the ZI reversed dopamine denervation-induced metabolic changes in SNr and GP. These improvements of metabolic activity were similar to those induced by HFS of the STN. Thus, the present results suggest that the ZI may directly or indirectly control basal ganglia activity and could therefore be implicated in the pathophysiology of Parkinson's disease. This hypothesis is further supported by recent data obtained in 6-OHDA lesioned rats showing that the functional activity of ZI neurons is increased after nigro-striatal dopaminergic denervation (64).
More recently, clinical studies using HFS for the treatment of Parkinson's disease have shown that the best clinical improvement of motor symptoms is achieved in the anterodorsal part of the STN and also in the dorsally adjacent ZI (25, 26) . Altogether, these experimental and clinical observations strongly support the notion of an involvement of the ZI in motor control exerted by the basal ganglia.
In the absence of a significant effect on STN metabolic activity, probably due to the sample size, we suggest that HFS of the ZI has a direct action on SNr neurons without the implication of the STN. From our results we can postulate that the prominent effect of ZI HFS on SNr metabolic activity may be due to the activation of GABAergic pallidonigral and/or striatonigral bundles resulting in the depression of neuronal activity in the SNr.
Our metabolic data suggest that ZI might be a good target for deep brain stimulation in Parkinson's disease. However, further studies are needed to understand the implication of ZI in the regulation of motricity. 
